Arcturus Therapeutics Holdings, Inc. (ARCT)
13.74
+0.87
(+6.76%)
USD |
NASDAQ |
Oct 09, 16:00
13.72
-0.02
(-0.15%)
Pre-Market: 20:00
Arcturus Therapeutics Holdings Free Cash Flow : -78.18M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -78.18M |
| March 31, 2026 | -63.18M |
| December 31, 2025 | -79.02M |
| September 30, 2025 | -61.49M |
| June 30, 2025 | -65.57M |
| March 31, 2025 | -89.82M |
| December 31, 2024 | -60.34M |
| September 30, 2024 | -61.26M |
| June 30, 2024 | -69.90M |
| March 31, 2024 | 10.50M |
| December 31, 2023 | -20.26M |
| September 30, 2023 | 132.65M |
| June 30, 2023 | 122.65M |
| March 31, 2023 | 37.95M |
| December 31, 2022 | 23.36M |
| September 30, 2022 | -174.50M |
| June 30, 2022 | -150.85M |
| March 31, 2022 | -149.86M |
| December 31, 2021 | -141.78M |
| September 30, 2021 | -103.58M |
| June 30, 2021 | -101.65M |
| March 31, 2021 | -77.10M |
| December 31, 2020 | -46.03M |
| September 30, 2020 | -45.91M |
| June 30, 2020 | -31.94M |
| Date | Value |
|---|---|
| March 31, 2020 | -13.92M |
| December 31, 2019 | -7.409M |
| September 30, 2019 | -5.089M |
| June 30, 2019 | -8.923M |
| March 31, 2019 | -26.35M |
| December 31, 2018 | -21.59M |
| September 30, 2018 | -6.04M |
| June 30, 2018 | -0.6003M |
| March 31, 2018 | 3.513M |
| December 31, 2017 | -0.7286M |
| September 30, 2017 | -14.52M |
| June 30, 2017 | -19.87M |
| March 31, 2017 | -19.86M |
| December 31, 2016 | -19.35M |
| September 30, 2016 | -19.66M |
| June 30, 2016 | -18.43M |
| March 31, 2016 | -18.22M |
| December 31, 2015 | -18.37M |
| September 30, 2015 | -20.14M |
| June 30, 2015 | -23.93M |
| March 31, 2015 | -25.47M |
| December 31, 2014 | -26.54M |
| September 30, 2014 | -25.55M |
| June 30, 2014 | -18.25M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Emergent BioSolutions, Inc. | 85.90M |
| Exelixis, Inc. | 1.172B |
| Ionis Pharmaceuticals, Inc. | -567.50M |
| United Therapeutics Corp. | 1.084B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.92M |
| Cash from Investing (Quarterly) | 0.0193M |
| Cash from Financing (Quarterly) | 0.0004M |
| Free Cash Flow Per Share (Quarterly) | -0.736 |
| Free Cash Flow to Equity (Quarterly) | -19.87M |
| Free Cash Flow to Firm (Quarterly) | -20.92M |
| Free Cash Flow Yield | -20.29% |